2004Chinese Journal of Drug Application and MonitoringRequires access

Clinical observation for the usage of glucocorticoid in the treatment of SARS

Gang Liu

Open publisher page 0 citations

Abstract

Objective:To investigate the usage of glucocorticoid in the treatment of severe acute respiratory syndrome (SARS). Methods:Thirty cases of SARS patients' clinical data were analyzed retrospectively.Results: All thirty were given methyl prednisone or prednisone and other comprehensive treatments such as anti-infection and anti-virus.The dosages of methyl prednisone per day were 80mg to 360mg,and that of prednisone were 20mg to 30mg.SARS patients' symptoms were better controlled after two to four days treatments. But some patients' states deteriorated when the dosages of glucocorticoid were reduced too early. These patients states became stable by increasing glucocorticoid dosage and enhancing other comprehensive treatments. Conclusion: Reducing the usage of glucocorticoidinin the SAILS treatment too early may lead to the disease deteriorating.

About this research paper

What this paper is about

Objective:To investigate the usage of glucocorticoid in the treatment of severe acute respiratory syndrome (SARS). Methods:Thirty cases of SARS patients' clinical data were analyzed retrospectively.Results: All thirty were given methyl prednisone or prednisone and other comprehensive treatments such as anti-infection and anti-virus.The dosages of methyl prednisone per day were 80mg to 360mg,and that of prednisone were 20mg to 30mg.SARS patients' symptoms were better controlled after two to four days treatments. But some patients' states deteriorated when the dosages of glucocorticoid were reduced too early. These patients states became stable by increasing glucocorticoid dosage and enhancing other comprehensive treatments. Conclusion: Reducing the usage of glucocorticoidinin the SAILS treatment too early may lead to the disease deteriorating.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To investigate the usage of glucocorticoid in the treatment of severe acute respiratory syndrome (SARS). Methods:Thirty cases of SARS patients' clinical data were analyzed retrospectively.Results: All thirty were given methyl prednisone or prednisone and other comprehensive treatments such as anti-infection and anti-virus.The dosages of methyl prednisone per day were 80mg to 360mg,and that of prednisone were 20mg to 30mg.SARS patients' symptoms were better controlled after two to four days treatments. But some patients' states deteriorated when the dosages of glucocorticoid were reduced too early. These patients states became stable by increasing glucocorticoid dosage and enhancing other comprehensive treatments. Conclusion: Reducing the usage of glucocorticoidinin the SAILS treatment too early may lead to the disease deteriorating.

Key concepts: Prednisone, Medicine, Glucocorticoid, Dose, Disease, Clinical trial, Coronavirus disease 2019 (COVID-19), Clinical study

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical observation for the usage of glucocorticoid in the treatment of SARS — Research Paper | ScholarLens